Literature DB >> 11018068

Latency and viral persistence in HIV-1 infection.

J D Siliciano1, R F Siliciano.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11018068      PMCID： PMC517817          DOI： 10.1172/JCI11246

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  17 in total

1.  Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

Authors:  T W Chun; R T Davey; M Ostrowski; J Shawn Justement; D Engel; J I Mullins; A S Fauci
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

2.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

Authors:  T W Chun; L Carruth; D Finzi; X Shen; J A DiGiuseppe; H Taylor; M Hermankova; K Chadwick; J Margolick; T C Quinn; Y H Kuo; R Brookmeyer; M A Zeiger; P Barditch-Crovo; R F Siliciano
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

3.  The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

Authors:  B Ramratnam; J E Mittler; L Zhang; D Boden; A Hurley; F Fang; C A Macken; A S Perelson; M Markowitz; D D Ho
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

4.  Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.

Authors:  G Dornadula; H Zhang; B VanUitert; J Stern; L Livornese; M J Ingerman; J Witek; R J Kedanis; J Natkin; J DeSimone; R J Pomerantz
Journal:  JAMA       Date:  1999-11-03       Impact factor: 56.272

5.  Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.

Authors:  M R Furtado; D S Callaway; J P Phair; K J Kunstman; J L Stanton; C A Macken; A S Perelson; S M Wolinsky
Journal:  N Engl J Med       Date:  1999-05-27       Impact factor: 91.245

6.  Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy.

Authors:  L Zhang; C Chung; B S Hu; T He; Y Guo; A J Kim; E Skulsky; X Jin; A Hurley; B Ramratnam; M Markowitz; D D Ho
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

7.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

8.  Viral dynamics in human immunodeficiency virus type 1 infection.

Authors:  X Wei; S K Ghosh; M E Taylor; V A Johnson; E A Emini; P Deutsch; J D Lifson; S Bonhoeffer; M A Nowak; B H Hahn
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

9.  In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

Authors:  T W Chun; D Finzi; J Margolick; K Chadwick; D Schwartz; R F Siliciano
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

10.  Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.

Authors:  M E Sharkey; I Teo; T Greenough; N Sharova; K Luzuriaga; J L Sullivan; R P Bucy; L G Kostrikis; A Haase; C Veryard; R E Davaro; S H Cheeseman; J S Daly; C Bova; R T Ellison; B Mady; K K Lai; G Moyle; M Nelson; B Gazzard; S Shaunak; M Stevenson
Journal:  Nat Med       Date:  2000-01       Impact factor: 87.241
View more
  12 in total

Review 1.  The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.

Authors:  Myron S Cohen; Nick Hellmann; Jay A Levy; Kevin DeCock; Joep Lange
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

2.  A mathematical model of HIV dynamics in the presence of a rescuing virus with replication deficiency.

Authors:  Elias Zintzaras; Axel Kowald
Journal:  Theory Biosci       Date:  2011-01-29       Impact factor: 1.919

3.  HIV infection: what should be considered in approaches for a cure?

Authors:  Jay A Levy; Yves Levy
Journal:  AIDS       Date:  2012-11-13       Impact factor: 4.177

4.  CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals.

Authors:  Alessandra Bandera; Giulio Ferrario; Marina Saresella; Ivana Marventano; Alessandro Soria; Fabio Zanini; Francesca Sabbatini; Monica Airoldi; Giulia Marchetti; Fabio Franzetti; Daria Trabattoni; Mario Clerici; Andrea Gori
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

5.  Characterization of an equine macrophage cell line: application to studies of EIAV infection.

Authors:  Isabel Fidalgo-Carvalho; Jodi K Craigo; Shannon Barnes; Carolina Costa-Ramos; Ronald C Montelaro
Journal:  Vet Microbiol       Date:  2008-11-01       Impact factor: 3.293

6.  Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda.

Authors:  Nicholas Musinguzi; Rain A Mocello; Yap Boum; Peter W Hunt; Jeffrey N Martin; Jessica E Haberer; David R Bangsberg; Mark J Siedner
Journal:  AIDS Behav       Date:  2017-06

7.  Mutations affecting interaction of integrase with TNPO3 do not prevent HIV-1 cDNA nuclear import.

Authors:  Alexandra Cribier; Emmanuel Ségéral; Olivier Delelis; Vincent Parissi; Aurélie Simon; Marc Ruff; Richard Benarous; Stéphane Emiliani
Journal:  Retrovirology       Date:  2011-12-16       Impact factor: 4.602

8.  The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses.

Authors:  Christy Anthonypillai; Julie E Gibbs; Sarah A Thomas
Journal:  Cerebrospinal Fluid Res       Date:  2006-01-03

9.  Small-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistance.

Authors:  Nadia Bakkour; Yea-Lih Lin; Sophie Maire; Lilia Ayadi; Florence Mahuteau-Betzer; Chi Hung Nguyen; Clément Mettling; Pierre Portales; David Grierson; Benoit Chabot; Philippe Jeanteur; Christiane Branlant; Pierre Corbeau; Jamal Tazi
Journal:  PLoS Pathog       Date:  2007-10-26       Impact factor: 6.823

Review 10.  Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses.

Authors:  Deepanwita Bose; Jean Gagnon; Yahia Chebloune
Journal:  Vet Sci       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.